Abstract
Radical surgery is the only therapeutic option that can ensure a long-term survival; until now many aspects of this disease have not been well-known, such as pathogenesis, and clinical and histopathologic factors that determine survival. In this chapter we will analyze the main prognostic factors that influence survival: macroscopic aspect, local extent, lymph-node involvement and distant metastases. Histological characteristics and molecular factors related to prognosis will also be analysed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hoang MP, Murakata LA, Katabi N et al. (2002) Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 15(12):1251–1258
Albores-Saavedra J, Murakata L, Krueger JE, Henson DE (2000) Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 89(3):508–515
Sakamoto E, Nimura Y, Hayakawa N et al (1998) The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227(3):405–411
Jarnagin WR, Bowne W, Klimstra DS et al (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241(5):703–712; discussion 712–714
Dinant S, Gerhards MF, Rauws EA et al (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumour). Ann Surg Oncol 13(6):872–80
Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240(1):95–101
Neuhaus P, Jonas S, Bechstein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230(6):808–818; discussion 819
Bhuiya MR, Nimura Y, Kamiya J et al (1992) Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215(4):344–349
Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238(5):720–727
Liu XF, Zhang H, Zhu SG et al (2006) Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol 12(29):4706–4709
Jarnagin WR, Klimstra DS, Hezel M et al (2006) Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24(7):1152–1160
Zervos EE, Osborne D, Goldin SB et al (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190(5):810–815
Itoi T, Shinohara Y, Takeda K et al (2000) Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endocs 52(3)380–386
Abdalla EK, Vauthey JN (2001) Biliary tract cancer. Curr Opin Gastroenterol 17(5):450–457
Rajala RV, Radhi JM, Kakkar R et al (2000) Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 88(9):1992–1999
Cormier JN, Vauthey JN (2000) Biliary tract cancer. Curr Opin Gastroenterol 16(5):437–443
Rashid A, Ueki T, Gao YT et al (2002) K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res 8(10):3156–3163
Hong SM, Cho H, Moskaluk CA, Yu E (2007) Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 31(2):199–206
Tabata M, Kawarada Y, Yokoi H et al (2000) Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7(2):148–154
Cha JM, Kim MH, Lee SK et al (2006) Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol (R Coll Radiol) 18(9):669–677
Mizumoto R, Ogura Y, Kusuda T (1993) Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterology 40(1):69–77
Kurosaki I, Tsukada K, Watanabe H, Hatakeyama K (1998) Prognostic determinants in extrahepatic bile duct cancer. Hepatogastroenterology 45(22):905–909
Bhuiya MR, Nimura Y, Kamiya J et al (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17(5):653–657
Hong SM, Kim MJ, Pi DY et al (2005) Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumour classification problems in 222 patients. Cancer 104(4):802–810
Nishio H, Nagino M, Oda K et al (2005) TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 390(4):319–327
Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph-node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233(3):385–392
Nakeeb A, Pitt HA, Sohn TA et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumours. Ann Surg 224(4):463–473; discussion 473–475
Sugiura Y, Nakamura S, Iida S et al (1994) Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 115(4):445–451
Iwatsuki S, Todo S, Marsh JW et al (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumours) with hepatic resection or transplantation. J Am Coll Surg 187(4):358–364
Ogura Y, Kawarada Y (1998) Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 85(1):20–24
Miyazaki M, Ito H, Nakagawa K et al (1999) Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 189(6):575–583
Kosuge T, Yamamoto J, Shimada K et al (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230(5):663–671
Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141(5):581–588
Hemming AW, Reed AI, Fujita S et al (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241(5):693–699; discussion 699–702
Launois B, Terblanche J, Lakehal M et al (1999) Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 230(2):266–275
Nagakawa T, Kayahara M, Ikeda S et al 0 Bilary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9(5):569–575
Lai EC, Lau WY (2005) Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg 75(11):981–985
Miyazaki M, Ito H, Nakagawa K et al (1998) Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 123(2):131–136
Gerhards MF, van Gulik TM, de Wit LT et al (2000) Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience. Surgery 127(4):395–404
Schwarz RE, Smith DD (2007) Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 11(2):158–165
Tojima Y, Nagino M, Ebata T et al (2003) Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 237(2):201–207
Taniguchi K, Tabata M, Iida T et al (2006) Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 32(2):208–212
Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24(2):189–199
Ramacciato G, Corigliano N, Mercantini P et al (2006) [Prognostic factors after surgical resection for hilar cholangiocarcinoma] Ann Chir 131(6–7):379–85, French
Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Guglielmi, A., Ruzzenente, A., Iacono, C. (2008). Prognostic Factors. In: Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0729-1_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-0729-1_8
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0728-4
Online ISBN: 978-88-470-0729-1
eBook Packages: MedicineMedicine (R0)